Sites: CDL-Oxford, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin
Stream: Advanced Therapies
Kevin Heyries is currently a business and strategy advisor working at the interface of science, innovation and investment with biotech, biopharma and VC groups. Kevin has over 15 years of R&D and translational research experience in biotechnology and therapeutics/biologics. He is a co-founder of AbCellera Biologics, having led AbCellera’s business development activities and key strategic partnerships with biopharmas, biotechs, and VCs, managing program design, negotiations, and alliances for several years. Prior to his departure from AbCellera, Kevin was a Director of Emerging Science and Technology at AbCellera. Before co-founding AbCellera, Kevin was conducting post-doctoral research at the University of British Columbia, where he focused on the development of high-sensitivity microfluidic digital PCR for genetic testing devices that were the basis for a commercial product. He has a PhD in Biochemistry from the University of Lyon and a master’s in Organic Chemistry/Biology from the University of Grenoble.
Kevin is a TEDx 2018 speaker and has been the recipient of the Top 40 Under 40 in Vancouver (2020) and Top 30 Under 40 young leaders transforming healthcare, Business Insider 2020 list. Outside work, his interests are focused on backcountry skiing, ski racing (CSC coach), mountain biking and long-distance trail running.